山河药辅(300452.SZ)通过美国FDA现场检查

Core Viewpoint - The company, Shanhe Pharmaceutical (300452.SZ), has successfully passed the FDA on-site inspection as confirmed by the issued Establishment Inspection Report (EIR) [1] Group 1 - The company received the EIR from the US FDA, indicating the completion of the on-site inspection [1] - The successful passing of the FDA inspection is a significant milestone for the company [1]